Canna Law Blog

AUGUST 31, 2023

As an HHS spokesperson explained: “While HHS’s scientific and medical evaluation is binding on DEA, the scheduling recommendation is not. For a fuller analysis, check out this old chestnut from 2016. Substances on lower schedules are simply more accessible from a DEA licensing perspective. This would be HUGE.

DEA 116

DEA Marijuana Banking Research and Development 116

FloridaMarijuana.net

JULY 16, 2018

Luckily, the trepidation of getting caught with medical marijuana has an easy solution nowadays. The Florida Health Department issues medical cannabis cards after a qualified physician has evaluated the patient, following Amendment 2 of the constitution, and if the patient suffers from a condition that renders him or her eligible for one.

Marijuana 189

Marijuana Patients Conditions Treatment 189

Cannabis Law Report

JANUARY 30, 2019

Access the full document at. To expand the number of manufacturers, the Drug Enforcement Administration (DEA) submitted a notice in the Federal Register on August 11, 2016, soliciting applications for licenses to manufacture marijuana for research purposes. Access the full document at.

Research and Development 63

Research and Development DEA CBD Law 63

Cannabis Law Report

MARCH 25, 2019

The Attorney General forwards the request to the Health and Human Services Secretary and requests a scientific and medical evaluation and recommendation, as specified by 23 USC 811(b-c). 2122 ) (relating to prohibitions governing atomic weapons), or section 104(a) of the North Korea Sanctions Enforcement Act of 2016 ? [3]

Banking 45

Banking Law Marijuana State Laws 45